类风湿关节炎患者减停TNF抑制剂中18F-FDG PET-CT的可靠性、有效性及预测价值
研究纳入减量策略随机对照试验中低疾病活动度、正在减停TNF抑制剂的类风湿关节炎患者,在减量前和最大减量后行FDG-PET,评估可靠性、结构与临床参数的关联及对18个月成功减量或停药的预测价值。定量评分可靠性好,肿胀关节与SUV相关,但FDG-PET评分不能预测成功减量或停药。
要点
- 定量FDG-PET关节炎评分在低疾病活动度RA患者中可靠性好,并有一定结构效度。
- 关节水平肿胀与SUVmax和SUVmean显著相关。
- FDG-PET参数不能预测TNF抑制剂成功减量或停药。
核心结论
- 低疾病活动度RA患者中定量FDG-PET关节炎评分可靠且有一定结构效度,但未发现FDG-PET参数对TNFi成功减量和/或停药有预测价值。
研究设计与样本
- 研究对象为皮下TNFi减量策略研究(Dose REduction Strategies of Subcutaneous TNFi study)减量组的RA患者,该研究为TNFi减量的随机对照试验。
- 患者在减量前(基线)和最大减量后接受FDG-PET,每次扫描对48个关节进行视觉评分(FDG高摄取关节,是/否)和定量评分(SUVmax和SUVmean)。
- 在10例患者基线时计算观察者间一致性,共79例患者接受FDG-PET。
主要发现
- 识别PET上FDG高摄取关节的Cohen κ为0.49(范围0.35-0.63)。
- SUVmax和SUVmean的组内相关系数分别为0.80(范围0.77-0.83)和0.96(范围0.9-1.0)。
- 关节水平上,肿胀与SUVmax和SUVmean显著相关,B系数分别为1.0(95%CI 0.73,1.35)和0.2(95%CI 0.08,0.32)。
- 患者水平上仅发现与急性期反应物相关。
- FDG-PET评分不能预测成功减量或停药。
关键数值与推荐
- 视觉识别FDG高摄取关节的Cohen κ为0.49(范围0.35-0.63)。
- SUVmax的组内相关系数为0.80(范围0.77-0.83),SUVmean为0.96(范围0.9-1.0)。
- 关节水平肿胀与SUVmax的B系数为1.0(95%CI 0.73,1.35),与SUVmean的B系数为0.2(95%CI 0.08,0.32)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the reliability and validity of fluorine-18 fluorodeoxyglucose (18F-FDG) PET-CT scanning (FDG-PET) in RA patients with low disease activity tapering TNF inhibitors (TNFis) and its predictive value for successful tapering or discontinuation. METHODS: Patients in the tapering arm of the Dose REduction Strategies of Subcutaneous TNFi study, a randomized controlled trial of TNFi tapering in RA, underwent FDG-PET before tapering (baseline) and after maximal tapering. A total of 48 joints per scan were scored both visually [FDG-avid joint (FAJ), yes/no] and quantitatively [maximal and mean standardized uptake values (SUVmax and SUVmean)]. Interobserver agreement was calculated in 10 patients at baseline. Quantitative and visual FDG-PET scores were investigated for (multilevel) association with clinical parameters both on a joint and patient level and for the predictive value at baseline and the change between baseline and maximal tapering (Δ) for successful tapering and discontinuation at 18 months. RESULTS: A total of 79 patients underwent FDG-PET. For performance of identification of FAJs on PET, Cohen's κ was 0.49 (range 0.35-0.63). For SUVmax and SUVmean, intraclass correlation coefficients were 0.80 (range 0.77-0.83) and 0.96 (0.9-1.0), respectively. On a joint level, swelling was significantly associated with SUVmax and SUVmean [B coefficients 1.0 (95% CI 0.73, 1.35) and 0.2 (0.08, 0.32), respectively]. On a patient level, only correlation with acute phase reactants was found. FDG-PET scores were not predictive of successful tapering or discontinuation. CONCLUSIONS: Quantitative FDG-PET arthritis scoring in RA patients with low disease activity is reliable and has some construct validity. However, no predictive values were found for FDG-PET parameters for successful tapering and/or discontinuation of TNFi.
引用
- Bouman CAM, van Herwaarden N, Blanken AB, et al. 18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value. Rheumatology (Oxford). 2022. PMID: 34791068. doi:10.1093/rheumatology/keab842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。